Dual-wavelength imaging of tumor progression by activatable and targeting near-infrared fluorescent probes in a bioluminescent breast cancer model

HIGHLIGHTS

• who: Activatable and collaborators from the Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, The Netherlands, Department of Otorhinolaryngology Head and Neck have published the article: Dual-Wavelength Imaging of Tumor Progression by Activatable and Targeting Near-Infrared Fluorescent Probes in a Bioluminescent Breast Cancer Model, in the Journal: (JOURNAL) of February/13,/2012
• what: The aim of this study was to explore the use of FLI as a viable and sensitive alternative to BLI.
• how: For this the authors employed different combinations of activatable and targeting NIRF probes in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.